.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

EVOXAC Drug Profile

« Back to Dashboard
Evoxac is a drug marketed by Daiichi Sankyo and is included in one NDA. It is available from four suppliers.

The generic ingredient in EVOXAC is cevimeline hydrochloride. There are four drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the cevimeline hydrochloride profile page.

Summary for Tradename: EVOXAC

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list4

Pharmacology for Tradename: EVOXAC

Clinical Trials for: EVOXAC

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Daiichi Sankyo
EVOXAC
cevimeline hydrochloride
CAPSULE;ORAL020989-002Jan 11, 2000RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: EVOXAC

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Daiichi Sankyo
EVOXAC
cevimeline hydrochloride
CAPSULE;ORAL020989-002Jan 11, 20004,855,290<disabled>
Daiichi Sankyo
EVOXAC
cevimeline hydrochloride
CAPSULE;ORAL020989-002Jan 11, 20005,580,880<disabled>
Daiichi Sankyo
EVOXAC
cevimeline hydrochloride
CAPSULE;ORAL020989-002Jan 11, 20005,340,821<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: EVOXAC

Drugname Dosage Strength RLD Submissiondate
cevimeline hydrochlorideCapsules30 mgEvoxac2/27/2009
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc